Orchestra BioMed Holdings, Inc. Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends
Orchestra BioMed Holdings, Inc. (OBIO) had Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends of 500.00 thousand shares as of 2023-04-12, per its 10-K filed 2025-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends · last filed 2025-03-31
- Orchestra BioMed Holdings, Inc. incremental common shares attributable to dilutive effect of nonvested shares with forfeitable dividends for the quarter ending 2023-03-31 was 500.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends | Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends 3 month |
|---|---|---|
| 2023-04-12 | 500.00K shares 10-K · filed 2025-03-31 | |
| 2023-03-31 | 500.00K shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |